A Study to Measure the Stigma of Skin Disorders as Experienced by Children

Overview

About this study

This study leverages the availability of a validated series of instruments to measure the effect of highly visible, chronic skin disorders, including atopic dermatitis (AD), on patients 8 years of age and above in causing stigma and psychiatric issues, particularly anxiety and depression.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

Subjects must be aged 8-17 years of age
Subject must be diagnosed with a chronic skin disease deemed to be severe enough and/or in a visible location that could be stigmatizing as determined by the study doctor
Subject and parent must both be English speaking with at least one parent/guardian who will complete the questionnaires
Subject and Parent/Guardian must be able to complete the relevant questionnaires

Exclusion Criteria:

Children under 8 years of age
Children with developmental delay and/or a behavioral disorder that would preclude participation in form completion
Children with a non-cutaneous disorder that is considered by the Study doctor to be stigmatizing

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location	Status
Rochester, Minn. Mayo Clinic principal investigator Megha Tollefson, M.D.	Closed for enrollment

Mayo Clinic Location

Status

Rochester, Minn.

Mayo Clinic principal investigator

Megha Tollefson, M.D.

Closed for enrollment

More information

Publications

Publications are currently not available

Clinical Trials